Web-economic-crisis-health-systems-and-health-web
Web-economic-crisis-health-systems-and-health-web Web-economic-crisis-health-systems-and-health-web
Country profiles of health system responses to the crisis | Cyprus 359 User charges • Introduction of a co-payment of €1 per prescription in private pharmacies (2012). • Introduction of new user charges of €10 for emergency department use, €0.50 per laboratory test (capped at €10 per referral), €0.50 per prescribed drug (capped at €10 per prescription) (from 1 August 2013). • Co-payments for a GP visit increased from €3 to €6 and for a specialist visit from €2 to €6. Beneficiaries over 65 years have to pay these copayments (previously they did not pay) (from 1 August 2013); • User charges increased for non-beneficiaries. More specifically they have to pay €15 for a GP visit and €30 for a specialist visit, instead of €14.5 and €15, respectively. Additionally non-beneficiaries have to pay 30% more for inpatient hospitalization and for all medical procedures, examinations and laboratory tests during their hospitalization (from 1 August 2013). Changes to health service planning, purchasing and delivery Prices of medical goods • Wholesale prices of prescription medicines in 10 EU countries to be considered when pricing; prices of new drugs costing over €10 to be updated every 12 months for the first two years and then every two years (2012). • Reduction of the profit cap from 37% to 33% for medical products of €50–250 (giving pharmacists a margin of around 25% of the retail price) and from 37% to 25% for products costing over €250 (pharmacist margin of around 20%) (2012). • VAT introduced for all pharmaceuticals at 5% (2011). • Introduction of a new surveillance mechanism to monitor polypharmacy in the public sector (2010). Salaries and motivation of health sector workers • Reduction in the salaries of all public sector health professionals (2011, 2012). • Additional scaled reductions in remuneration of public sector employees and pension recipients (2012). • Overtime rates reduced (2012). Payment to providers • In accordance with the MoU, the Ministry of Health is required to move from national case-based payment for hospitals to a DRG system (2013).
360 Economic crisis, health systems and health in Europe: country experience • The Pancyprian Medical Association urged doctors in the private sector to reduce prices of outpatient visits and medical procedures (2012). • The Pancyprian Medical Association froze prices included in the list of services agreed with the insurance companies until the end of 2013. Overhead costs: restructuring the Ministry of Health and purchasing agencies • Procurement moved to the Ministry of Health (2011). Provider infrastructure and capital investment • The Council of Ministers approved the Ministry of Health's proposal for the reorganization of public hospitals (2012). The proposal aimed to increase cost control and improve quality by reinforcing managerial structures, allocating budgets to each hospital and clinic and creating hospital clusters between neighbouring districts. In order to facilitate implementation, the Ministry of Health prepared a new structure for the clinics in each hospital, which was approved by trade unions (2012). Priority setting or protocols to change access to treatments, coordination of care and patterns of use • Planned to introduce protocols and financial disincentives (user charges) to minimize the provision of medically unnecessary laboratory tests and drugs (second quarter of 2013). Waiting times • No response reported. Health promotion and prevention • Excise duties increased on tobacco products, beer and alcoholic products (2013).
- Page 342 and 343: Chapter 9 | The impact of the crisi
- Page 344 and 345: Chapter 9 | The impact of the crisi
- Page 346 and 347: Chapter 9 | The impact of the crisi
- Page 348 and 349: Chapter 9 | The impact of the crisi
- Page 350 and 351: Chapter 9 | The impact of the crisi
- Page 352: Chapter 9 | The impact of the crisi
- Page 356 and 357: Albania Genc Burazeri and Enver Ros
- Page 358 and 359: Country profiles of health system r
- Page 360 and 361: Country profiles of health system r
- Page 362 and 363: Austria Thomas Czypionka and Maria
- Page 364 and 365: Country profiles of health system r
- Page 366 and 367: Azerbaijan Fuad Ibrahimov Economic
- Page 368 and 369: Country profiles of health system r
- Page 370 and 371: Country profiles of health system r
- Page 372 and 373: Country profiles of health system r
- Page 374 and 375: Country profiles of health system r
- Page 376 and 377: Country profiles of health system r
- Page 378 and 379: Country profiles of health system r
- Page 380 and 381: Country profiles of health system r
- Page 382 and 383: Bulgaria Antoniya Dimova and Mina P
- Page 384 and 385: Country profiles of health system r
- Page 386 and 387: Country profiles of health system r
- Page 388 and 389: Country profiles of health system r
- Page 390 and 391: Cyprus Elisavet Constantinou and Ma
- Page 394 and 395: Czech Republic Tomáš Roubal and J
- Page 396 and 397: Country profiles of health system r
- Page 398 and 399: Country profiles of health system r
- Page 400 and 401: Country profiles of health system r
- Page 402 and 403: Country profiles of health system r
- Page 404 and 405: Estonia Triin Habicht and Mall Lein
- Page 406 and 407: Country profiles of health system r
- Page 408 and 409: Finland Jan Klavus and Lauri Vuoren
- Page 410 and 411: Country profiles of health system r
- Page 412 and 413: France Karine Chevreul, Karen Berg
- Page 414 and 415: Country profiles of health system r
- Page 416 and 417: Country profiles of health system r
- Page 418 and 419: Country profiles of health system r
- Page 420 and 421: Germany Klaus-Dirk Henke and Wilm Q
- Page 422 and 423: Country profiles of health system r
- Page 424 and 425: Country profiles of health system r
- Page 426 and 427: Country profiles of health system r
- Page 428 and 429: Country profiles of health system r
- Page 430 and 431: Country profiles of health system r
- Page 432 and 433: Country profiles of health system r
- Page 434 and 435: Iceland Sigrún Gunnarsdóttir and
- Page 436 and 437: Country profiles of health system r
- Page 438 and 439: Ireland Anne Nolan and Steve Thomas
- Page 440 and 441: Country profiles of health system r
360 Economic <strong>crisis</strong>, <strong>health</strong> <strong>systems</strong> <strong>and</strong> <strong>health</strong> in Europe: country experience<br />
• The Pancyprian Medical Association urged doctors in the private sector<br />
to reduce prices of outpatient visits <strong>and</strong> medical procedures (2012).<br />
• The Pancyprian Medical Association froze prices included in the list of<br />
services agreed with the insurance companies until the end of 2013.<br />
Overhead costs: restructuring the Ministry of Health <strong>and</strong> purchasing agencies<br />
• Procurement moved to the Ministry of Health (2011).<br />
Provider infrastructure <strong>and</strong> capital investment<br />
• The Council of Ministers approved the Ministry of Health's proposal<br />
for the reorganization of public hospitals (2012). The proposal aimed<br />
to increase cost control <strong>and</strong> improve quality by reinforcing managerial<br />
structures, allocating budgets to each hospital <strong>and</strong> clinic <strong>and</strong> creating<br />
hospital clusters between neighbouring districts. In order to facilitate<br />
implementation, the Ministry of Health prepared a new structure for<br />
the clinics in each hospital, which was approved by trade unions (2012).<br />
Priority setting or protocols to change access to treatments, coordination<br />
of care <strong>and</strong> patterns of use<br />
• Planned to introduce protocols <strong>and</strong> financial disincentives (user charges)<br />
to minimize the provision of medically unnecessary laboratory tests <strong>and</strong><br />
drugs (second quarter of 2013).<br />
Waiting times<br />
• No response reported.<br />
Health promotion <strong>and</strong> prevention<br />
• Excise duties increased on tobacco products, beer <strong>and</strong> alcoholic products<br />
(2013).